| 3.00 Data as of Dec 10 |  -0.05 / -1.64%Today’s Change | 2.85 Today|||52-Week Range 7.80 | -59.57% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $35.0M |
XTL Biopharmaceuticals Ltd. Herzliya Business Park Herzliya -- 46766 |
| Mutual fund holders | 1.12% |
| Other institutional | 0.10% |
| Individual stakeholders | -- |
| David Grossman | Chief Executive Officer & Executive Director |
| Ronen Twito | Chief Financial Officer & Deputy CEO |
| Moshe Mittelman | Medical Director |
| Daniel Shapira | Internal Auditor |
| Navon Shalom | Controller |
.
